Lloyd Tillman

fDA Guidance for Industry 1 Dissolution Testing of Immediate Release Solid Oral Dosage Forms

Vinod P. Shah, Lawrence J. Lesko, Jim Fan et al. · Dissolution Technologies · 1997 · 140 citations · Full text

Improvement of the encapsulation efficiency of oligonucleotide-containing biodegradable microspheres

T Freytag, Andrei Dashevsky, Lloyd Tillman et al. · Journal of Controlled Release · 2000 · 132 citations

Encapsulation Efficiency, Micro-encapsulation

Oral Delivery of Antisense Oligonucleotides in Man

Lloyd Tillman, Richard S. Geary, Gregory E. Hardee · Journal of Pharmaceutical Sciences · 2007 · 124 citations

Nanomedicine, Medicine, Oligonucleotide +5

An oral antisense oligonucleotide for PCSK9 inhibition

Peter Gennemark, Katrin Walter, Niclas Clemmensen et al. · Science Translational Medicine · 2021 · 117 citations

FDA Guidance for Industry 1 Extended Release Solid Oral Dosage forms: Development, Evaluation, and Application of In Vitro/In Vivo Correlations

Henry Malinowski, Patrick Marroum, Venkata Ramana Uppoor et al. · Dissolution Technologies · 1997 · 88 citations · Full text